Episode 822: Conexeu Sciences ($CNXU): The Future of Regenerative Aesthetics

This interview is disseminated on behalf of Conexeu Sciences Inc.Conexeu Sciences (NASDAQ: CNXU) President and CEO Miles Harrison discusses how the company’s regenerative medicine platform could address the growing demand for tissue restoration driven by GLP-1 weight loss medications, extracellular matrix technology, multi-market strategy, and the future of bioregeneration.Learn more: https://www.conexeu.com/Watch the full YouTube interview here: https://youtu.be/FJUXvMrH5hUAnd follow us to stay updated: https://www.youtube.com/GlobalOneMedia